Shukra Pharmaceuticals Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

184.45

+3.60 (+1.99%)

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

NSE BSE

Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals

184.45

+3.60 (+1.99%)
16:01 Jan 10

Quality

62/100
High Financial Strength

Valuation

15/100
Expensive Valuation

Technical

77/100
Technically Bullish

Strength

Weakness

Opportunity

Threats

ROE %

ROA %

EPS

BVPS

Net Profit Margin

Income Statement Balance sheet Cash flow Ratio Shareholding

Quarterly Annual

Consolidated Standalone

	Mar 2021	Mar 2022	Mar 2023	Mar 2024	TTM 2024
Net Sales	11.2	20.49	58.83	74.57	38.51
Operating Expenses +	9.76	17.6	53.47	55.17	23.06
Raw Material	2.96	11.08	45.65	43.79	13.22
Increase Decrease in Cost	-0.19	-0.73	-0.33	0.7	-1.92
Other Manufacturing Expense	0	0	0	0	0
Employee Cost	4.07	4.9	4.89	5.65	5.74
Miscellaneous Expenses	2.92	2.35	71.86	65.85	6.02
Operating Profit	1.44	2.89	5.36	19.4	15.45
Other Income	0.36	0.08	1.2	2.82	3.68
Depreciation	1.47	1.66	1.84	2.05	2.4
Interest	0.03	0.29	0.28	0.28	0.31
Profit before tax and exceptio..	0.29	1.02	4.44	19.88	16.42
Exceptional Items	-0.2	0	0	0	0
PBT	0.1	1.02	4.44	19.88	16.42
Provision for Taxation	0.06	0.27	0.04	1.35	2
Net Profit	0.03	0.75	4.41	18.54	14.44
NET Profit after MI	0	0	0	0	0
EPS	0.22	4.79	26.21	16.93	12.61
Operating Profit Margin (%)	12.86	14.1	9.11	26.02	40.12
Net Profit Margin (%)	0.27	3.66	7.5	24.86	37.5

ShareHolding

All Data in Percentage (%)

	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23
Promoter	51.00	51.00	51.00	51.00	50.90
FII	0.00	0.00	0.00	0.00	0.00
MF	0.00	0.00	0.00	0.00	0.00
Public	48.90	48.90	48.90	48.90	49.00
Others	0.00	0.00	0.00	0.00	0.00
Others	0.10	0.10	0.10	0.10	0.10